Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
暂无分享,去创建一个
J. Tang | T. Kern | J Tang | T S Kern | R A Kowluru | R. Kowluru | Jie-long Tang
[1] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. , 1999, Free radical biology & medicine.
[2] D. Godin,et al. Alterations in Free Radical Tissue-Defense Mechanisms in Streptozocin-Induced Diabetes in Rat: Effects of Insulin Treatment , 1987, Diabetes.
[3] T. Kern,et al. Experimental Galactosemia Produces Diabetic-like Retinopathy , 1984, Diabetes.
[4] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[5] N. Laver,et al. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. , 1990, Experimental eye research.
[6] G. Romeo,et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.
[7] G. Lutty,et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. , 1998, Free radical biology & medicine.
[8] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine , 2000, Current eye research.
[9] Alan W. Stitt,et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. , 1997, The American journal of pathology.
[10] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[11] A. Cerami,et al. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.
[12] J. Witztum,et al. Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. A. North,et al. Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. , 1996, Free radical biology & medicine.
[14] D. Armstrong,et al. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. , 1992, Journal of diabetes and its complications.
[15] M. Mcdaniel,et al. Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.
[16] W. Li,et al. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. , 1999, Cellular and molecular biology.
[17] S. J. Chen,et al. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. , 1992, Biochemical and biophysical research communications.
[18] N. Farid,et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. , 1998, Diabetes.
[19] Y. Akagi,et al. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. , 1990, Archives of ophthalmology.
[20] G. King,et al. Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.
[21] G. King,et al. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus , 1997, Journal of Molecular Medicine.
[22] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. , 1994, Current eye research.
[23] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. , 1997, Free radical biology & medicine.
[24] R. Unger,et al. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.
[25] A. Azzi,et al. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. , 1994, European journal of biochemistry.
[26] A. Mansour,et al. Prevention of pericyte loss by trolox in diabetic rat retina. , 1998, Journal of toxicology and environmental health. Part A.
[27] B. Reboussin,et al. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. , 1998, Ophthalmology.
[28] T. Kern,et al. Galactose-induced retinal microangiopathy in rats. , 1995, Investigative ophthalmology & visual science.
[29] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[30] T. Kern,et al. A mouse model of diabetic retinopathy. , 1996, Archives of ophthalmology.
[31] B. Mayer,et al. Inhibition of purified soluble guanylyl cyclase by L-ascorbic acid. , 2000, Cardiovascular research.
[32] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. , 1994, Investigative ophthalmology & visual science.
[33] T. Kern,et al. Diabetes-induced metabolic abnormalities in myocardium: Effect of antioxidant therapy , 2000, Free radical research.
[34] W. Pryor. Vitamin E and heart disease: basic science to clinical intervention trials. , 2000, Free radical biology & medicine.
[35] K. H. Kim,et al. High glucose can induce lipid peroxidation in the isolated rat glomeruli. , 1994, Kidney international.
[36] T. Kern,et al. Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.
[37] H. Hammes,et al. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.
[38] G. King,et al. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. , 1997, Journal of the American Society of Nephrology : JASN.
[39] T. Kern,et al. Retinal glutamate in diabetes and effect of antioxidants , 2001, Neurochemistry International.
[40] T. Kern,et al. Retinopathy in animal models of diabetes. , 1995, Diabetes/metabolism reviews.
[41] R. Cohen,et al. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.